D
DnaNudge
DNA-based guidance for personalized shopping and health choices
About DnaNudge
DnaNudge is a health-tech startup that operates in the consumer genomics market. The company offers a unique service that uses DNA-based recommendations to nudge consumers towards healthier lifestyle choices. The company's primary customers are individuals seeking to improve their health and wellness through personalized, data-driven insights.
Read full description
DnaNudge's business model revolves around a DNA testing service. Customers provide a DNA sample, which the company analyzes to identify specific genetic traits related to nutrition and skincare. The results are then used to provide personalized product recommendations. Customers can scan product barcodes while shopping to see if the product is a good match for their genetic profile, indicated by a simple red or green signal.
The company also offers an 'Active Nudge' service, which monitors customers' inactivity levels and updates their DNA-based recommendations in real time. This service is designed to encourage customers to make healthier choices throughout the day.
DnaNudge generates revenue through the sale of its DNA testing kits and the ongoing use of its recommendation service. The company's unique approach to personal health and wellness, combined with its innovative use of genomics technology, positions it well in the growing consumer genomics market.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- London, United Kingdom
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 64.2/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Weight Management, DNA, Genetics and genomics, Remote Monitoring, Nutrition, Health Diagnostics, Microbiome, Spinout
- Business model
- Manufacturing
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Aug 2021 | $60M | $240M | Julius Baer Group · Ventura Capital | ↗ |
| EARLY VCOther financing | Jul 2018 | $6.6M | $26M | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for DnaNudge is 120 monthly website visits, down 85.5% over the last three months. DnaNudge's team declined 26.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Ventura Capital
Julius Baer Group
Other known investors1 additional known investor
Imperial College London
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about DnaNudge on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See DnaNudge’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.